Platelets effects on tumor growth

Seminars in Oncology

Volumn 41, Issue 3, 2014, Pages 359-369

  Goubran, Hadi A ^a   Stakiw, Julie ^a   Radosevic, Mirjana ^b   Burnouf, Thierry ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b HUMAN PROTEIN PROCESS SCIENCES   (France)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CYTOLOGY; DISTANT METASTASIS; EXTRAVASATION; HUMAN; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; THROMBOCYTE; TUMOR GROWTH;

ANIMALS; BLOOD PLATELETS; DISEASE PROGRESSION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84904160958     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.04.006     Document Type: Article

References (83)

1. B. Cooper Osler's role in defining the third corpuscle, or "blood plates" Proceedings (Baylor University Medical Center) 18 4 2005 376
2. M. Leslie Cell biology. Beyond clotting: the powers of platelets Science 328 5978 2010 562 564
3. E. Bastida, L. Almirall, and A. Ordinas Tumor cell induced platelet aggregation is a glycoprotein dependent and lipoxygenase associated process Int J Cancer 39 6 1987 760 763
4. H.A. Goubran, T. Burnouf, M. Radosevic, and M. El-Ekiaby The platelet-cancer loop Eur J Int Med 24 5 2013 393 400
5. F. Cognasse, H. Hamzeh, P. Chavarin, S. Acquart, C. Genin, and O. Garraud Evidence of Toll-like receptor molecules on human platelets Immunol Cell Biol 83 2 2005 196 198
6. G. Andonegui, S.M. Kerfoot, K. McNagny, K.V. Ebbert, K.D. Patel, and P. Kubes Platelets express functional Toll-like receptor-4 Blood 106 7 2005 2417 2423
7. F. Cognasse, H. Hamzeh Cognasse, S. Lafarge, O. Delezay, B. Pozzetto, and A. McNicol et al. Toll like receptor 4 ligand can differentially modulate the release of cytokines by human platelets Br J Haematol 141 1 2008 84 91
8. N. Bambace, and C. Holmes The platelet contribution to cancer progression J Thromb Haemost 9 2 2011 237 249
9. S. Sabrkhany, A.W. Griffioen, and M.G. Oude Egbrink The role of blood platelets in tumor angiogenesis Biochim Biophys Acta 1815 2 2011 189 196
10. Burnouf T, Goubran H, Chou ML, Devos D, Radosevic M. Platelet microparticles: detection and assessment of paradoxical roles in diseases and regenerative medicine. Blood Rev. 2014. 10.1016/j.blre.2014.04.002.
11. Smyth S, Whiteheart S, Italiano JE, Coller B, (eds). Platelet morphophology, biochemistry and function. New York, NY: McGraw Hill; 2010:1735
12. L. Kurtz, L. Kao, D. Newman, I. Kurtz, and Q. Zhu Integrin αIIbβ3 Inside-out activation an in situ conformational analysis reveals a new mechanism J Biol Chem 287 27 2012 23255 23265
13. C. Gachet, B. Hechler, and C. Leon et al. Purinergic receptors on blood platelets Platelets 7 5-6 1996 261 267
14. M.R. Cunningham, S.P. Nisar, and S.J. Mundell Molecular mechanisms of platelet P2Y 12 receptor regulation Biochem Soc Transact 41 1 2013 225 230
15. E.R. Vandendries, B.C. Furie, and B. Furie Role of P-selectin and PSGL-I in coagulation and thrombosis Thromb Haemost 92 3 2004 459 466
16. K. Suzuki-Inoue, O. Inoue, G. Ding, S. Nishimura, K. Hokamura, and K. Eto et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets J Biol Chem 285 32 2010 24494 24507
17. K. Miyazono, and F. Takaku Platelet-derived growth factors Blood Rev 3 4 1989 269 276
18. H. Pinedo, H. Verheul, R. D'amato, and J. Folkman Involvement of platelets in tumour angiogenesis? Lancet 352 9142 1998 1775 1777
19. H.A. Goubran, J. Stakiw, M. Radosevic, and T. Burnouf Platelet-cancer interactions Semin Thromb Hemost 40 3 2014 296 305
20. G.N. Wogan, S.S. Hecht, J.S. Felton, A.H. Conney, and L.A. Loeb Environmental and chemical carcinogenesis Semin Cancer Biol 2004 473 486
21. Y.K. Shim, J.M. Rachel, and P. Ghia et al. Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding Blood 2013 (blood-2013-2008-523704)
22. W.G. Nieto, J. Almeida, A. Romero, C. Teodosio, A. López, and A.F. Henriques et al. Increased frequency (12%) of circulating CLL-like B-cell clones in healthy individuals using a high-sensitive multicolor flow cytometry approach Blood 114 1 2009 33 37
23. Goubran HA, Kotb RR, Stakiw JK, Emara ME, Burnouf T. Regulation of tumor growth and metastasis: the role of tumor milieu. Cancer Growth Metast. In press.
24. H. Goubran, and T. Burnouf Platelets, coagulation and cancer: multifaceted interactions Am Med J 3 2 2012 130 140
25. G.J. Gasic, T.B. Gasic, and C.C. Stewart Antimetastatic effects associated with platelet reduction Proc Natl Acad Sci U S A 61 1 1968 46
26. E. Heinmöller, T. Schropp, and O. Kisker et al. Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines Scand J Gastroenterol 30 10 1995 1008 1016
27. E. Heinmöller, R.J. Weinel, H.H. Heidtmann, U. Salge, R. Seitz, and I. Schmitz et al. Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines J Cancer Res Clin Oncol 122 12 1996 735 744
28. P. Jurasz, D. Alonso Escolano, and M.W. Radomski Platelet-cancer interactions: mechanisms and pharmacology of tumour cell induced platelet aggregation Br J Pharmacol 143 7 2004 819 826
29. L. Oleksowicz, and J.P. Dutcher Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategies Med Oncol 12 2 1995 95 102
30. H. Chopra, J.S. Hatfield, Y.S. Chang, I.M. Grossi, L.A. Fitzgerald, and C.Y. O'Gara et al. Role of tumor cell cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregation Cancer Res 48 13 1988 3787 3800
31. L. Oleksowicz, Z. Mrowiec, E. Schwartz, M. Khorshidi, J.P. Dutcher, and E. Puszkin Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIbIIIa expression by MCF-7 breast cancer cells Thromb Res 79 3 1995 261 274
32. Y.Q. Chen, M. Trikha, X. Gao, R. Bazaz, A.T. Porter, and J. Timar et al. Ectopic expression of platelet integrin αIIbβ3 in tumor cells from various species and histological origin Int J Cancer 72 4 1997 642 648
33. M. Chen, and J.-G. Geng P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis Arch Immunol Ther Exp 54 2 2006 75 84
34. L.A. Coupland, B.H. Chong, and C.R. Parish Platelets and p-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells Cancer Res 72 18 2012 4662 4671
35. S. Takagi, S. Sato, T. Oh-hara, M. Takami, S. Koike, and Y. Mishima et al. Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2 PloS One 8 8 2013 e73609
36. A. Kunita, T.G. Kashima, Y. Morishita, M. Fukayama, Y. Kato, and T. Tsuruo et al. The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis Am J Pathol 170 4 2007 1337 1347
37. K.L. Lowe, L. Navarro-Nunez, and S.P. Watson Platelet CLEC-2 and podoplanin in cancer metastasis Thromb Res 129 2012 S30 S37
38. R.T. Dorsam, and S.P. Kunapuli Central role of the P2Y12 receptor in platelet activation J Clin Invest 113 3 2004 340 345
39. M. Wojtukiewicz, L. Zacharski, V. Memoli, W. Kisiel, B.J. Kudryk, and S.M. Rousseau et al. Fibrinogen-fibrin transformation in situ in renal cell carcinoma Anticancer Res 10 3 1990 579
40. C. Milsom, and J. Rak Tissue factor and cancer Pathophysiol Haemost Thromb 36 3-4 2008 160
41. N. Bambace, J. Levis, and C. Holmes The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets Platelets 21 2 2010 85
42. S. Barrientos, O. Stojadinovic, M. Golinko, H. Brem, and M. Tomic-Canic Growth factors and cytokines in wound healing Wound Rep Reg 16 5 2008 585
43. H. Goel, and A. Mercurio VEGF targets the tumour cell Nature Rev Cancer 13 12 2013 871
44. G. Martiny-Baron, and D. Marmé VEGF-mediated tumour angiogenesis: a new target for cancer therapy Curr Opin Biotechnol 6 6 1995 675 680
45. R.K. Jain, D.G. Duda, J.W. Clark, and J.S. Loeffler Lessons from phase III clinical trials on anti-VEGF therapy for cancer Nat Clin Pract Oncol 3 1 2006 24 40
46. Z. Wang, and H. Huang Platelet factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy Cancer Lett 331 2 2013 147 153
47. J.F. Di Stefano, M. Kirchner, K. Dagenhardt, and N. Hagag Activation of cancer cell proteases and cytotoxicity by EGF and PDGF growth factors Am J Med Sci 300 1 1990 9 15
48. T. Gaarenstroom, and C.S. Hill TGF-β signaling to chromatin: how Smads regulate transcription during self-renewal and differentiation Semin Cell Dev Biol 2014
49. B.A. Teicher Malignant cells, directors of the malignant process: role of transforming growth factor-beta Cancer Metast Rev 20 1-2 2001 133 143
50. Y. Drabsch, and P. ten Dijke TGF-β signalling and its role in cancer progression and metastasis Cancer Metast Rev 31 3-4 2012 553 568
51. P.J. Jenkins, and S.A. Bustin Evidence for a link between IGF-I and cancer Eur J Endocrinol 151 Suppl 1 2004 S17 S22
52. A. Grimberg Mechanisms by which IGF-I may promote cancer Cancer Biol Ther 2 6 2003 630 635
53. E.C. Chu, and A.S. Tarnawski PTEN regulatory functions in tumor suppression and cell biology Med Sci Monit 10 10 2004 RA235 RA241
54. H.-A. Kim, K.H. Seo, Y.-R. Kang, H.M. Ko, K.J. Kim, and H.K. Back et al. Mechanisms of platelet-activating factor-induced enhancement of VEGF expression Cell Physiol Biochem 27 1 2011 55 62
55. M.-C. Cathcart, K. Gately, R. Cummins, E. Kay, K.J. O'Byrne, and G.P. Pidgeon Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer Mol Cancer 10 1 2011 25
56. D. Varon, Y. Hayon, O. Dashevsky, and E. Shai Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration Thromb Res 130 2012 S98 S99
57. A. Falanga, C.J. Tartari, and M. Marchetti Microparticles in tumor progression Thromb Res 129 2012 S132 S136
58. D. Rönnlund, Y. Yang, H. Blom, G. Auer, and J. Widengren Fluorescence nanoscopy of platelets resolves platelet state specific storage, release and uptake of proteins, opening up future diagnostic applications Adv Healthcare Materials 1 6 2012 707 713
59. J.S. Palumbo, K.E. Talmage, J.V. Massari, C.M. La Jeunesse, M.J. Flick, and K.W. Kombrinck et al. Platelets and fibrin (ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells Blood 105 1 2005 178 185
60. H.-G. Kopp, T. Placke, and H.R. Salih Platelet-derived transforming growth factor-β down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity Cancer Res 69 19 2009 7775 7783
61. Y. Lee, L. Lee, C. Su, G. Hsiao, Y.Y. Yang, and S.J. Leu et al. Virally inactivated human platelet concentrate lysate induces regulatory T cells and immunosuppressive effect in a murine asthma model Transfusion 53 9 2013 1918 1928
62. G. Dranoff The therapeutic implications of intratumoral regulatory T cells Clin Cancer Res 11 23 2005 8226 8229
63. N. Reymond, B.B. d'Água, and A.J. Ridley Crossing the endothelial barrier during metastasis Nature Rev Cancer 13 12 2013 858 870
64. S.M. Weis, and D.A. Cheresh αv Integrins in angiogenesis and cancer Cold Spring Harbor Perspect Med 1 1 2011 a006478
65. C. Anderberg, S.I. Cunha, Z. Zhai, E. Cortez, E. Pardali, and J.R. Johnson et al. Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination J Exp Med 210 3 2013 563 579
66. T. Placke, H.-G. Kopp, and H.R. Salih The wolf in sheep's clothing: Platelet-derived "pseudo self" impairs cancer cell "missing self" recognition by NK cells OncoImmunology 1 4 2012 557 559
67. M. Labelle, S. Begum, and R.O. Hynes Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis Cancer Cell 20 5 2011 576 590
68. Y. Kienast, L. von Baumgarten, M. Fuhrmann, W.E. Klinkert, R. Goldbrunner, and J. Herms et al. Real-time imaging reveals the single steps of brain metastasis formation Nature Med 16 1 2010 116 122
69. S. Ito, H. Nakanishi, Y. Ikehara, T. Kato, Y. Kasai, and K. Ito et al. Real time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line Int J Cancer 93 2 2001 212 217
70. A.B. Malik Pulmonary microembolism Physiol Rev 63 3 1983 1114 1207
71. 2+/calmodulin-dependent protein kinase II mediates platelet-derived growth factor-induced human hepatic stellate cell proliferation Dig Dis Sci 57 4 2012 935 942
72. D. Sharma, K.E. Brummel Ziedins, B.A. Bouchard, and C.E. Holmes Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer J Cell Physiol 229 8 2014 1005 1015
73. P. Salari Sharif, and M. Abdollahi The role of platelets in bone remodeling Inflam Allergy Drug Targets 9 5 2010 393 399
74. O. Peyruchaud, R. Leblanc, and M. David Pleiotropic activity of lysophosphatidic acid in bone metastasis Biochim Biophys Acta 1831 1 2013 99 104
75. H. Agis, S. Schröckmair, C. Skorianz, M.B. Fischer, G. Watzek, and R. Gruber Platelets increase while serum reduces the differentiation and activity of osteoclasts in vitro J Orthop Res 31 10 2013 1561 1569
76. P. Maitz, B. Kandler, M.B. Fischer, G. Watzek, and R. Gruber Activated platelets retain their potential to induce osteoclast-like cell formation in murine bone marrow cultures Platelets 17 7 2006 477 483
77. M.J. Thun, M.M. Namboodiri, and C.W. Heath Jr Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325 23 1991 1593 1596
78. A.M. Algra, and P.M. Rothwell Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials Lancet Oncol 13 5 2012 518 527
79. P.M. Rothwell, M. Wilson, J.F. Price, J.F. Belch, T.W. Meade, and Z. Mehta Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials Lancet 379 9826 2012 1591 1601
80. N.R. Cook, I.-M. Lee, J.M. Gaziano, D. Gordon, P.M. Ridker, and J.E. Manson et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial JAMA 294 1 2005 47 55
81. N.R. Cook, I.-M. Lee, S.M. Zhang, M.V. Moorthy, and Buring JE. Alternate-day low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial Ann Intern Med 159 2 2013 77 85
82. G. Lippi, and E.J. Favaloro Recombinant platelet factor 4: a therapeutic, anti-neoplastic chimera? Semin Thromb Hemost 2010 558 569
83. G. Hariri, Y. Zhang, A. Fu, Z. Han, M. Brechbiel, and M.N. Tantawy et al. Radiation-guided P-selectin antibody targeted to lung cancer Ann Biomed Engineer 36 5 2008 821 830